VanEck Associates
PBYI icon

VanEck Associates’s Puma Biotechnology PBYI Stock Holding History

VanEck Associates’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-19,237
Closed -$573K – 880
2016
Q2 		$573K Sell
19,237
-20,382
-51% -$637K ﹤0.01% 534
2016
Q1 		$1.16M Buy
39,619
+5,163
+15% +$233K 0.01% 420
2015
Q4 		$2.7M Buy
34,456
+1,047
+3% +$82.2K 0.02% 283
2015
Q3 		$2.52M Sell
33,409
-16,716
-33% -$1.58M 0.02% 297
2015
Q2 		$5.85M Buy
50,125
+867
+2% +$157K 0.03% 246
2015
Q1 		$11.6M Sell
49,258
-6,617
-12% -$1.41M 0.07% 194
2014
Q4 		$10.6M Buy
55,875
+5,515
+11% +$1.22M 0.07% 197
2014
Q3 		$12M Buy
+50,360
New +$10.3M 0.06% 184

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return